Centergene Pharmaceuticals

Shanghai Bao Pharmaceutical, a Chinese pharmaceutical company, along with its wholly-owned subsidiary Suzhou Centergene Pharmaceuticals, has announced a significant supply and transfer agreement with Organon China, a US-based healthcare firm specializing in women’s health. The agreement grants Organon exclusive commercialization rights for Bao Pharma’s SJ02 in mainland China. SJ02, developed…